Jixiang Wu

1.2k total citations
77 papers, 838 citations indexed

About

Jixiang Wu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Jixiang Wu has authored 77 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 22 papers in Cancer Research and 20 papers in Surgery. Recurrent topics in Jixiang Wu's work include RNA modifications and cancer (20 papers), Cancer-related molecular mechanisms research (17 papers) and Circular RNAs in diseases (8 papers). Jixiang Wu is often cited by papers focused on RNA modifications and cancer (20 papers), Cancer-related molecular mechanisms research (17 papers) and Circular RNAs in diseases (8 papers). Jixiang Wu collaborates with scholars based in China, United States and Canada. Jixiang Wu's co-authors include Chaojie Liang, Hua Ge, Yingchen Xu, Guangming Li, Yajun Zhang, Guangming Li, Tianzi Jiang, Guangyao Jiang, Xuntao Yin and Xiaohu Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Jixiang Wu

70 papers receiving 827 citations

Peers

Jixiang Wu
Soroush Doostkam Germany
Oneil G. Bhalala Australia
Soo-Kyoung Kim South Korea
Myung Woul Han South Korea
Akiko Misawa Japan
Marios Themistocleous Greece
Ming‐Fu Chiang Taiwan
Michael P. Lazaropoulos United States
Tao Sun China
Soroush Doostkam Germany
Jixiang Wu
Citations per year, relative to Jixiang Wu Jixiang Wu (= 1×) peers Soroush Doostkam

Countries citing papers authored by Jixiang Wu

Since Specialization
Citations

This map shows the geographic impact of Jixiang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jixiang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jixiang Wu more than expected).

Fields of papers citing papers by Jixiang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jixiang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jixiang Wu. The network helps show where Jixiang Wu may publish in the future.

Co-authorship network of co-authors of Jixiang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jixiang Wu. A scholar is included among the top collaborators of Jixiang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jixiang Wu. Jixiang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xuefeng, Jixiang Wu, Xuedong Wei, et al.. (2025). Targeting ferroptosis in prostate cancer management: molecular mechanisms, multidisciplinary strategies and translational perspectives. Journal of Translational Medicine. 23(1). 166–166. 3 indexed citations
2.
3.
Zhang, Dongdong, Limin Guo, Jixiang Wu, Ning Ning, & Lin Chen. (2025). Progress and future prospects for the surgical treatment of permanent hypoparathyroidism after thyroid surgery: a narrative review. BMC Surgery. 26(1). 64–64.
4.
5.
Zou, Tao, et al.. (2024). PAQR6 as a prognostic biomarker and potential therapeutic target in kidney renal clear cell carcinoma. Frontiers in Immunology. 15. 1521629–1521629.
6.
Wu, Jixiang, et al.. (2023). The efficacy and safety of fluoxetine versus placebo for stroke recovery: a meta-analysis of randomized controlled trials. International Journal of Clinical Pharmacy. 45(4). 839–846. 6 indexed citations
7.
Chen, Weiwei, Xia Li, Longfei Yang, et al.. (2023). Pancancer analysis of the correlations of HS6ST2 with prognosis, tumor immunity, and drug resistance. Scientific Reports. 13(1). 19209–19209. 1 indexed citations
8.
Wu, Jixiang, et al.. (2023). Comparison of Lasmiditan 200 mg Versus 100 mg for Migraine Patients: A Meta-analysis of Randomized Controlled Studies. Clinical Neuropharmacology. 47(1). 1–6. 1 indexed citations
9.
Yi, ZhongQuan, et al.. (2022). NUF2 Is a Potential Immunological and Prognostic Marker for Non-Small-Cell Lung Cancer. Journal of Immunology Research. 2022. 1–22. 6 indexed citations
10.
11.
Zhang, Xiaohu & Jixiang Wu. (2021). LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-β pathway in gastric cancer. Pathology - Research and Practice. 224. 153492–153492. 17 indexed citations
12.
Ge, Hua, et al.. (2018). DcR3 induces proliferation, migration, invasion, and EMT in gastric cancer cells via the PI3K/AKT/GSK-3β/β-catenin signaling pathway. OncoTargets and Therapy. Volume 11. 4177–4187. 32 indexed citations
13.
Wu, Jixiang, Yajun Zhang, Jixiang Song, et al.. (2018). Inactivation of SMARCA2 by promoter hypermethylation drives lung cancer development. Gene. 687. 193–199. 36 indexed citations
14.
Liang, Chaojie, Yingchen Xu, Hua Ge, Guangming Li, & Jixiang Wu. (2018). Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma. OncoTargets and Therapy. Volume 11. 1203–1214. 12 indexed citations
15.
Liang, Chaojie, Jinghong Zhang, Hua Ge, et al.. (2018). Long non-coding RNA CASC2 in solid tumors: A meta-analysis. Clinica Chimica Acta. 486. 357–368. 5 indexed citations
16.
Liang, Chaojie, Jing Liu, Hua Ge, et al.. (2018). The clinicopathological and prognostic value of long non-coding RNA ZEB1-AS1 in solid tumors: A meta-analysis. Clinica Chimica Acta. 484. 91–98. 7 indexed citations
17.
Wang, Yu, et al.. (2017). A Technique of Endoscopic Nipple-Sparing Mastectomy for Breast Cancer. JSLS Journal of the Society of Laparoscopic & Robotic Surgeons. 21(2). e2017.00028–e2017.00028. 19 indexed citations
18.
Ge, Hua, et al.. (2017). Desarda versus Lichtenstein technique for the treatment of primary inguinal hernia: A systematic review. International Journal of Surgery. 50. 22–27. 21 indexed citations
19.
Li, Yanru, et al.. (2015). Effects of Altered Intra-abdominal Pressure on the Upper Airway Collapsibility in a Porcine Model. Chinese Medical Journal. 128(23). 3204–3210. 5 indexed citations
20.
Zhou, Jingan, et al.. (2015). Application of Video-Assisted Thyroidectomy for Cervicomediastinal Goiter. Journal of Laparoendoscopic & Advanced Surgical Techniques. 25(11). 926–931.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soroush Doostkam Breakdown of academic impact, for papers by Oneil G. Bhalala Breakdown of academic impact, for papers by Soo-Kyoung Kim Breakdown of academic impact, for papers by Myung Woul Han Breakdown of academic impact, for papers by Akiko Misawa Breakdown of academic impact, for papers by Marios Themistocleous Breakdown of academic impact, for papers by Ming‐Fu Chiang Breakdown of academic impact, for papers by Michael P. Lazaropoulos Breakdown of academic impact, for papers by Tao Sun
Rankless by CCL
2026